http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
1 online resource (xxiv, 368 pages) : illustrations (some color)
"At Glasgow Royal Infirmary historically diabetes and clinical pharmacology were linked with specialists in each discipline contributing to one of the medical units in the provision of general medical care to the inhabitants of the east of Glasgow whilst delivering specialist expertise. A few miles north of the Royal Infirmary, Stobhill Hospital in its prime had physicians delivering care who were also delivering academic excellence in the Department of Materia Medica at the University of Glasgow. In 2011 the two hospitals in the northeast of Glasgow merged to provide in patient care on one site and in doing so brought together the prospect of having a combined Department of Diabetes, Endocrinology and Clinical Pharmacology. In addition to having a long-standing reputation for recruiting patients to commercial studies, the Royal Infirmary has strong links with the University of Glasgow, with senior academics continuing to provide both general and specialist patient care, and the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, specifically around training independent pharmacy prescribers. Education and training have been hallmarks of the department and in 2008 a series of Drug Notes was established for Practical Diabetes, covering drugs used in those with diabetes but not necessarily ones for lowering blood glucose, encouraging trainees to be first authors. The series is still going, suggesting that an understanding of drugs is an essential part of being a healthcare provider with an interest in diabetes. Antidiabetic drugs were covered in two separate series for the British Journal of Cardiology, again with trainees aspiring to be specialists in diabetes and endocrinology being first authors and to consider clinical pharmacology as a key knowledge skill"--
Clinical pharmacology of antidiabetic drugs / Andrea Llano, Gerry McKay, and Ken Paterson -- Metformin / Joseph G. Timmons and James G. Boyle -- Sulfonylureas and meglitinides -- Joseph G. Timmons and James G. Boyle -- DPP-4 inhibitors / Sharon Mackin and Gemma Currie -- SGLT2 inhibitors / Miles Fisher, Andrea Llano, and Gerry McKay -- GLP-1 receptor agonists / Catherine Russell and John R. Petrie -- Animal and human insulin / Ken Paterson -- Short-ccting insulin analogues / Kate Hughes and Gerry McKay -- Long-acting Insulin Analogues / Robert Lindsay -- Devices / David Carty -- Acarbose and alpha glucosidase inhibitors / Miles Fisher -- Glitazones and glitazars / Miles Fisher -- Other antidiabetic drugs / Maroria Oroko, Andrea Llano, and Miles Fisher -- Future antidiabetic drugs / Emma Johns and Miles Fisher -- Guidelines / Miles Fisher and Russell Drummond -- Prescribing antidiabetic drugs / Andrea Llano, Gerry McKay, Frances McManus, Catriona McClements, Joyce McKenzie, and Deborah Morrison.
edited by Miles Fisher, Gerard A. McKay, Andrea Llano.
Includes bibliographical references and index.